Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2013 (2013), Article ID 808353, 7 pages
http://dx.doi.org/10.1155/2013/808353
Review Article

Pathophysiology of Vascular Remodeling in Hypertension

1Department of Pathology, School of Medicine, National University of Cuyo, Avenida Libertador 80, Centro Universitario, 5500 Mendoza, Argentina
2Institute of Experimental Medicine and Biology of Cuyo (IMBECU), CONICET, Mendoza, Argentina
3Department of Physiology, School of Medicine, Universidad Complutense, Plaza de Ramón y Cajal s.n., 28040 Madrid, Spain

Received 16 January 2013; Revised 2 May 2013; Accepted 16 May 2013

Academic Editor: Kazuomi Kario

Copyright © 2013 Nicolás F. Renna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Glagov, E. Weisenberg, C. K. Zarins, R. Stankunavicius, and G. J. Kolettis, “Compensatory enlargement of human atherosclerotic coronary arteries,” The New England Journal of Medicine, vol. 316, no. 22, pp. 1371–1375, 1987. View at Google Scholar · View at Scopus
  2. F. Feihl, L. Liaudet, B. Waeber, and B. I. Levy, “Hypertension: a disease of the microcirculation?” Hypertension, vol. 48, no. 6, pp. 1012–1017, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Mulvany, O. K. Hansen, and C. Aalkjaer, “Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers,” Circulation Research, vol. 43, no. 6, pp. 854–864, 1978. View at Google Scholar · View at Scopus
  4. E. L. Schiffrin, L. Y. Deng, and P. Larochelle, “Morphology of resistance arteries and comparison of effects of vasocontrictors in mild essential hypertensive patients,” Clinical and Investigative Medicine, vol. 16, no. 3, pp. 177–186, 1993. View at Google Scholar · View at Scopus
  5. D. Rizzoni, M. Castellano, E. Porteri, G. Bettoni, M. L. Muiesan, and E. Agabiti-Rosei, “Vascular structural and functional alterations before and after the development of hypertension in SHR,” American Journal of Hypertension, vol. 7, no. 2, pp. 193–200, 1994. View at Google Scholar · View at Scopus
  6. P. I. Korner and J. A. Angus, “Vascular remodeling,” Hypertension, vol. 29, no. 4, pp. 1065–1066, 1997. View at Google Scholar · View at Scopus
  7. M. J. Mulvany, “Small artery remodeling in hypertension,” Current Hypertension Reports, vol. 4, no. 1, pp. 49–55, 2002. View at Google Scholar · View at Scopus
  8. G. Simon, “Pathogenesis of structural vascular changes in hypertension,” Journal of Hypertension, vol. 22, no. 1, pp. 3–10, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Mulvany, “Small artery structure: time to take note?” American Journal of Hypertension, vol. 20, no. 8, pp. 853–854, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. H. Gibbons and V. J. Dzau, “The emerging concept of vascular remodeling,” The New England Journal of Medicine, vol. 330, no. 20, pp. 1431–1438, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. G. L. Baumbach and D. D. Heistad, “Remodeling of cerebral arterioles in chronic hypertension,” Hypertension, vol. 13, no. 6, pp. 968–972, 1989. View at Google Scholar · View at Scopus
  12. M. J. Mulvany, “Vascular remodelling of resistance vessels: can we define this?” Cardiovascular Research, vol. 41, no. 1, pp. 9–13, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Bund and R. M. K. W. Lee, “Arterial structural changes in hypertension: a consideration of methodology, terminology and functional consequence,” Journal of Vascular Research, vol. 40, no. 6, pp. 547–557, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Mulvany, “Structural abnormalities of the resistance vasculature in hypertension,” Journal of Vascular Research, vol. 40, no. 6, pp. 558–560, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. W. R. Dunn and S. M. Gardiner, “Differential alteration in vascular structure of resistance arteries isolated from the cerebral and mesenteric vascular beds of transgenic [(mRen-2)27], hypertensive rats,” Hypertension, vol. 29, no. 5, pp. 1140–1147, 1997. View at Google Scholar · View at Scopus
  16. H. Hashimoto, R. L. Prewitt, and C. W. Efaw, “Alterations in the microvasculature of one-kidney, one-clip hypertensive rats,” American Journal of Physiology, vol. 253, no. 4, pp. H933–H940, 1987. View at Google Scholar · View at Scopus
  17. N. Korsgaard and M. J. Mulvany, “Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats,” Hypertension, vol. 12, no. 2, pp. 162–167, 1988. View at Google Scholar · View at Scopus
  18. H. D. Intengan, L. Y. Deng, J. S. Li, and E. L. Schiffrin, “Mechanics and composition of human subcutaneous resistance arteries in essential hypertension,” Hypertension, vol. 33, no. 1, pp. 569–574, 1999. View at Google Scholar · View at Scopus
  19. G. L. Baumbach and D. D. Heistad, “Remodeling of cerebral arterioles in chronic hypertension,” Hypertension, vol. 13, no. 6, pp. 968–972, 1989. View at Google Scholar · View at Scopus
  20. A. M. Heagerty, C. Aalkjaer, S. J. Bund, N. Korsgaard, and M. J. Mulvany, “Small artery structure in hypertension: dual processes of remodeling and growth,” Hypertension, vol. 21, no. 4, pp. 391–397, 1993. View at Google Scholar · View at Scopus
  21. G. Pasterkamp, Z. S. Galis, and D. P. V. de Kleijn, “Expansive arterial remodeling: location, location, location,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 650–657, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Libby, “Inflammation and cardiovascular disease mechanisms,” The American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 456S–460S, 2006. View at Google Scholar
  23. H. Nakane, F. J. Miller Jr., F. M. Faraci, K. Toyoda, and D. D. Heistad, “Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction,” Hypertension, vol. 35, no. 2, pp. 595–601, 2000. View at Google Scholar · View at Scopus
  24. N. F. Renna, C. Lembo, M. C. Lama, E. S. González, and R. M. Miatello, “Vascular repair by endothelial progenitor cells in an experimental model of metabolic syndrome,” in Handbook on Metabolic Syndrome: Classification, Risk Factors and Health Impact, C. M. Lopez Garcia and P. A. Perez Gonzalez, Eds., Nova Science Publishers, New York, NY, USA, 1st edition, 2012. View at Google Scholar
  25. C. Viedt, J. Vogel, T. Athanasiou et al., “Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-κB and activator protein-1,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 6, pp. 914–920, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. M. N. Sack, “Tumor necrosis factor-α in cardiovascular biology and the potential role for anti-tumor necrosis factor-α therapy in heart disease,” Pharmacology and Therapeutics, vol. 94, no. 1-2, pp. 123–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Patti, G. Di Sciascio, A. D'Ambrosio, G. Dicuonzo, A. Abbate, and A. Dobrina, “Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention,” American Journal of Cardiology, vol. 89, no. 4, pp. 372–376, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Hernández-Rodríguez, M. Segarra, C. Vilardell et al., “Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism,” Circulation, vol. 107, no. 19, pp. 2428–2434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. R. de Waal Malefyt, J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries, “Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes,” The Journal of Experimental Medicine, vol. 174, no. 5, pp. 1209–1220, 1991. View at Google Scholar · View at Scopus
  30. Z. S. Galis, G. K. Sukhova, M. W. Lark, and P. Libby, “Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques,” Journal of Clinical Investigation, vol. 94, no. 6, pp. 2493–2503, 1994. View at Google Scholar · View at Scopus
  31. H. Uzui, A. Harpf, M. Liu et al., “Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines,” Circulation, vol. 106, no. 24, pp. 3024–3030, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Pasceri, J. T. Willerson, and E. T. H. Yeh, “Direct proinflammatory effect of C-reactive protein on human endothelial cells,” Circulation, vol. 102, no. 18, pp. 2165–2168, 2000. View at Google Scholar · View at Scopus
  33. S. K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, and I. Jialal, “Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells,” Circulation, vol. 106, no. 12, pp. 1439–1441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Luc, J. M. Bard, I. Juhan-Vague et al., “C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 7, pp. 1255–1261, 2003. View at Publisher · View at Google Scholar
  35. I. M. van der Meer, M. P. M. de Maat, A. J. Kiliaan, D. A. M. van der Kuip, A. Hofman, and J. C. M. Witteman, “The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam study,” Archives of Internal Medicine, vol. 163, no. 11, pp. 1323–1328, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. D. J. Freeman, J. Norrie, M. J. Caslake et al., “C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study,” Diabetes, vol. 51, no. 5, pp. 1596–1600, 2002. View at Google Scholar · View at Scopus
  37. R. M. Touyz, D. Endemann, G. He, J.-S. Li, and E. L. Schiffrin, “Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR,” Hypertension, vol. 33, no. 1, pp. 366–372, 1999. View at Google Scholar · View at Scopus
  38. R. M. Touyz, G. He, M. El Mabrouk, Q. Diep, V. Mardigyan, and E. L. Schiffrin, “Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats,” Journal of Hypertension, vol. 19, no. 3, pp. 553–559, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. L.-J. Min, M. Mogi, J. Iwanami et al., “Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence,” Cardiovascular Research, vol. 76, no. 3, pp. 506–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. L.-J. Min, M. Mogi, J.-M. Li, J. Iwanami, M. Iwai, and M. Horiuchi, “Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells,” Circulation Research, vol. 97, no. 5, pp. 434–442, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. N. J. Brown, “Aldosterone and vascular inflammation,” Hypertension, vol. 51, no. 2, pp. 161–167, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Rizzoni, E. Porteri, G. E. M. Boari et al., “Prognostic significance of small-artery structure in hypertension,” Circulation, vol. 108, no. 18, pp. 2230–2235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. O. N. Mathiassen, N. H. Buus, I. Sihm et al., “Small artery structure is an independent predictor of cardiovascular events in essential hypertension,” Journal of Hypertension, vol. 25, no. 5, pp. 1021–1026, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Aalkjaer, A. M. Heagerty, K. K. Petersen, J. D. Swales, and M. J. Mulvany, “Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives,” Circulation Research, vol. 61, no. 2, pp. 181–186, 1987. View at Google Scholar · View at Scopus
  45. N. Korsgaard, C. Aalkjaer, A. M. Heagerty, A. S. Izzard, and M. J. Mulvany, “Histology of subcutaneous small arteries from patients with essential hypertension,” Hypertension, vol. 22, no. 4, pp. 523–526, 1993. View at Google Scholar · View at Scopus
  46. A. S. Izzard, E. J. Cragoe Jr., and A. M. Heagerty, “Intracellular pH in human resistance arteries in essential hypertension,” Hypertension, vol. 17, no. 6, pp. 780–786, 1991. View at Google Scholar · View at Scopus
  47. P. A. Thürmann, N. Stephens, A. M. Heagerty, P. Kenedi, G. Weidinger, and N. Rietbrock, “Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries,” Hypertension, vol. 28, no. 3, pp. 450–456, 1996. View at Google Scholar · View at Scopus
  48. E. L. Schiffrin, J. B. Park, H. D. Intengan, and R. M. Touyz, “Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan,” Circulation, vol. 101, no. 14, pp. 1653–1659, 2000. View at Google Scholar · View at Scopus
  49. J. B. Park and E. L. Schiffrin, “Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension,” Journal of Hypertension, vol. 19, no. 5, pp. 921–930, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. J. M. Harazny, M. Ritt, D. Baleanu et al., “Increased wall: lumen ratio of retinal arterioles in male patients with a history of a cerebrovascular event,” Hypertension, vol. 50, no. 4, pp. 623–629, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. R. M. K. W. Lee, “Vascular changes at the prehypertensive phase in the mesenteric arteries from spontaneously hypertensive rats,” Blood Vessels, vol. 22, no. 3, pp. 105–126, 1985. View at Google Scholar · View at Scopus
  52. A. Takeshita, T. Imaizumi, T. Ashihara, K. Yamamoto, S. Hoka, and M. Nakamura, “Limited maximal vasodilator capacity of forearm resistance vessels in normotensive young men with a familial predisposition to hypertension,” Circulation Research, vol. 50, no. 5, pp. 671–677, 1982. View at Google Scholar · View at Scopus
  53. C. Giannattasio, B. M. Cattaneo, A. A. Mangoni et al., “Cardiac and vascular structural changes in normotensive subjects with parental hypertension,” Journal of Hypertension, vol. 13, no. 2, pp. 259–264, 1995. View at Google Scholar · View at Scopus